What is he best known for?
The fields of study Makoto Sugaya is best known for:
- Cancer
- Gene
- Immune system
His Medication adherence research extends to the thematically linked field of Internal medicine.
His Medication adherence study frequently draws connections to other fields, such as Internal medicine.
Many of his studies involve connections with topics such as Serum amyloid A and Immunology.
He performs multidisciplinary study in Serum amyloid A and Tumor necrosis factor alpha in his work.
By researching both Tumor necrosis factor alpha and Interleukin, he produces research that crosses academic boundaries.
He undertakes interdisciplinary study in the fields of Interleukin and Cytokine through his research.
He performs integrative study on Cytokine and Inflammation in his works.
As part of his studies on Inflammation, Makoto Sugaya often connects relevant subjects like Systemic inflammation.
His studies link Immunology with Systemic inflammation.
His most cited work include:
- Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking (125 citations)
- FDG-PET in T-cell and NK-cell neoplasms (122 citations)
- Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (80 citations)
What are the main themes of his work throughout his whole career to date
His study in the field of Biochemistry also crosses realms of Cancer research.
In his study, Makoto Sugaya carries out multidisciplinary Biochemistry and Gene research.
His work often combines Cancer research and Genetics studies.
Genetics is closely attributed to Cell culture in his research.
He undertakes interdisciplinary study in the fields of Immunology and Cytokine through his works.
He regularly ties together related areas like Disease in his Internal medicine studies.
His work in Pathology is not limited to one particular discipline; it also encompasses Scleroderma (fungus).
His study connects Inoculation and Scleroderma (fungus).
As part of his studies on Inoculation, he often connects relevant subjects like Pathology.
Makoto Sugaya most often published in these fields:
- Immunology (47.83%)
- Internal medicine (43.48%)
- Pathology (34.78%)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
